Abstract
Inborn errors of the IL-17-mediated signaling have been associated with chronic mucocutaneous candidiasis (CMC). We describe a patient with CMC, atopic dermatitis, enamel dysplasia, and recurrent parotitis harboring a novel compound heterozygous mutation of TRAF3IP2, leading to autosomal recessive ACT1 deficiency and deficient IL-17 signaling.
| Original language | English |
|---|---|
| Pages (from-to) | 1376 - 1379 |
| Journal | Journal Of Clinical Immunology |
| Volume | 41 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - Aug 2021 |
Keywords
- ACT1
- Candida spp
- chronic mucocutaneous candidiasis
- IL-17
- TRAF3IP2
Fingerprint
Dive into the research topics of 'A Novel TRAF3IP2 Mutation Causing Chronic Mucocutaneous Candidiasis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver